Characteristic | n |
No. of patients | 467 |
Sex | |
Men | 250 |
Women | 217 |
Age (y) | |
Median | 59 |
Range | 17–88 |
No. of patients older than 60 y | 210 (45) |
Lymphoma subtype | |
FL I–III a | 271 (58) |
Diffuse large B-cell lymphoma | 94 (20) |
Mantle cell lymphoma | 65 (14) |
B-chronic lymphatic leukemia | 24 (5.1) |
Marginal zone lymphoma | 13 (2.8) |
Stage | |
I | 24 (5.2) |
II | 63 (13.5) |
III | 104 (22.3) |
IV | 268 (57.4) |
E | 4 (0.9) |
Not determined | 4 (0.9) |
Previous therapies | |
Chemotherapy | 445 |
1–3 | 342 (77) |
4–6 | 89 (20) |
>7 | 14 (3) |
Radioimmunotherapy | 22 (4.7) |
Autologous stem cell transplantation | |
1 | 63 (13.4) |
2 | 3 (0.6) |
Radiotherapy | 88 |
1 | 67 (76) |
2 | 16 (18) |
≥3 | 5 (6) |
Bone marrow infiltration before radioimmunotherapy | |
No. of patients | 467 |
Infiltration | 72 (15) |
<20% | 59 (13) |
>20% | 13 (3) |
Data in parentheses are percentages.